Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Mexico Reversible Contraceptive Devices (IUDs, Hormonal Implants, Diaphragms) Outlook to 2033: Market Revenue, Volume, Pricing and Competitive Analysis

globenewswire.com
ORGO Organon is listed as a key company in the North America Reversible Contraceptive Devices Market, but no specific performance or outlook is provided for the company in the article. DARE Dare Bioscience received significant grant funding ($3.6M and $4M) and regained rights to Ovaprene, indicating positive developments and ongoing program progress.

Mexico Reversible Contraceptive Devices (IUDs, Hormonal Implants, Diaphragms) Outlook to 2033: Market Revenue, Volume, Pricing and Competitive Analysis Dublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- "Mexico Reversible Contraceptive Devices Market Outlook to 2033 - Intrauterine Devices (IUDs), Hormonal Implants and Diaphragms" has been added to ResearchAndMarkets.com's offering.

The reportis a comprehensive databook providing detailed analysis of the Mexico Reversible Contraceptive Devices Market. The report delivers historical and forecast market data across three principal segments: Intrauterine Devices (IUDs), Hormonal Implants and Diaphragms.

Designed to support strategic planning, investment assessment and competitive intelligence, the report presents annualized market revenues in USD, sales volume in units and average prices in USD. Data coverage extends from 2018 through 2033, enabling users to assess historical performance, current market conditions and anticipated developments across each product segment.

Key Information Included in the Report

Mexico Reversible Contraceptive Devices Market Segmentation

The segmentation framework allows users to compare revenue, unit volume and average pricing trends by product category. This structured market intelligence can help organizations identify segments with favorable growth prospects, evaluate changes in demand and assess the commercial positioning of established and emerging participants.

Strategic Value of the Report

The Mexico Reversible Contraceptive Devices Market report supports the development of informed business strategies by highlighting product segments expected to demonstrate strong growth through 2033. Its historical and forecast datasets can assist companies in evaluating market-entry opportunities, planning geographic or portfolio expansion and prioritizing resources according to projected market potential.

Competitive share information provides insight into who-stands-where in the market, helping organizations assess the relative position of leading participants and formulate competition strategies. Company profiles further support benchmarking by presenting relevant corporate information and, where available, pipeline products, recent news and deals.

Investors, manufacturers, distributors, healthcare market participants and strategy teams can use the report to evaluate market size, pricing conditions and future opportunities. The analysis also assists in developing investment strategies by identifying segments expected to register strong growth in the near future.

Reasons to Buy

By combining market revenues, unit volumes, average prices, competitive shares and company intelligence, the Mexico Reversible Contraceptive Devices Outlook to 2033 provides an evidence-based resource for assessing commercial opportunities and supporting decisions within Mexico's reversible contraceptive devices sector.

Key Topics Covered

1 Table of Contents

1.1 List of Tables [25]

1.2 List of Figures [20]

2 Introduction

2.1 What Is This Report About?

2.2 Reversible Contraceptive Devices Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Reversible Contraceptive Devices Market, North America

3.1 Reversible Contraceptive Devices Market, North America, Revenue ($m), 2018-2033

3.2 Reversible Contraceptive Devices Market, North America, Volume (Units), 2018-2033

3.3 Reversible Contraceptive Devices Market, North America, Company Share by Revenue ($m), 2025

4 Reversible Contraceptive Devices Market, Canada

4.1 Reversible Contraceptive Devices Market, Canada, Revenue ($m), 2018-2033

4.1.1 Intrauterine Devices (IUDs) Market, Canada, Revenue ($m), by Segment, 2018-2033

4.2 Reversible Contraceptive Devices Market, Canada, Volume (Units), 2018-2033

4.2.1 Intrauterine Devices (IUDs) Market, Canada, Volume (Units), by Segment, 2018-2033

4.3 Reversible Contraceptive Devices Market, Canada, Average Price ($), 2018-2033

4.4 Reversible Contraceptive Devices Market, Canada, Company Share by Revenue ($m), 2025

5 Reversible Contraceptive Devices Market, Mexico

5.1 Reversible Contraceptive Devices Market, Mexico, Revenue ($m), 2018-2033

5.1.1 Intrauterine Devices (IUDs) Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.2 Reversible Contraceptive Devices Market, Mexico, Volume (Units), 2018-2033

5.2.1 Intrauterine Devices (IUDs) Market, Mexico, Volume (Units), by Segment, 2018-2033

5.3 Reversible Contraceptive Devices Market, Mexico, Average Price ($), 2018-2033

5.4 Reversible Contraceptive Devices Market, Mexico, Company Share by Revenue ($m), 2025

6 Reversible Contraceptive Devices Market, United States

6.1 Reversible Contraceptive Devices Market, United States, Revenue ($m), 2018-2033

6.1.1 Intrauterine Devices (IUDs) Market, United States, Revenue ($m), by Segment, 2018-2033

6.2 Reversible Contraceptive Devices Market, United States, Volume (Units), 2018-2033

6.2.1 Intrauterine Devices (IUDs) Market, United States, Volume (Units), by Segment, 2018-2033

6.3 Reversible Contraceptive Devices Market, United States, Average Price ($), 2018-2033

6.4 Reversible Contraceptive Devices Market, United States, Company Share by Revenue ($m), 2025

7 Overview of Key Companies in North America Reversible Contraceptive Devices Market

7.1 Organon

7.1.1 Company Overview

7.2 Bayer AG

7.2.1 Company Overview

7.3 Allergan Aesthetics

7.3.1 Company Overview

7.4 CooperSurgical Inc

7.4.1 Company Overview

8 Reversible Contraceptive Devices Market Pipeline Products

9 Recent Developments

9.1 Corporate Communications

9.1.1 Nov 24, 2025: Dare Bioscience Receives $3.6 Million in Additional Grant Funding

9.1.2 Oct 06, 2025: Dare Bioscience Secures $4 Million Grant, Totaling $41.8 Million Received

9.2 Product News

9.2.1 Dec 01, 2025: Dare Bioscience Regains Rights to Ovaprene; Phase 3 Program Ongoing

For more information about this report visit https://www.researchandmarkets.com/r/csc4rf

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.